(Q46002085)

English

Mortality rate in neonates infected with extended-spectrum beta lactamase-producing Klebsiella species and selective empirical use of meropenem.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19460263

Mortality rate in neonates infected with extended-spectrum beta lactamase-producing Klebsiella species and selective empirical use of meropenem. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19460263

author name string

S Velaphi

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19460263

J Wadula

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19460263

F Nakwa

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19460263

publication date

1 June 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19460263

Annals of Tropical Paediatrics

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19460263

29

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19460263

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19460263

101-110

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19460263

Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Emergence of multidrug-resistant gram-negative organisms in a neonatal unit and the therapeutic implications

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Multiresistant Klebsiella pneumoniae in a neonatal nursery: the importance of maintenance of infection control policies and procedures in the prevention of outbreaks

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Outbreak of extended spectrum beta lactamase producing Klebsiella pneumoniae in a neonatal unit

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

A simultaneous outbreak on a neonatal unit of two strains of multiply antibiotic resistant Klebsiella pneumoniae controllable only by ward closure.

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Involvement of SHV-12 and SHV-2a encoding plasmids in outbreaks of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a Tunisian neonatal ward

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy.

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae.

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Prevalence and mechanisms of decreased susceptibility to carbapenems in Klebsiella pneumoniae isolates.

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Clinical features of nosocomial infections by extended-spectrum beta-lactamase-producing Enterobacteriaceae in neonatal intensive care units

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Piperacillin/tazobactam in the treatment of Klebsiella pneumoniae infections in neonates.

1 reference

https://api.crossref.org/works/10.1179%2F146532809X440716

21 January 2018

Identifiers

10.1179/146532809X440716

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19460263

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19460263

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46002085&oldid=907313395"